How Zevra’s Miplyffa Could Transform Investment Strategies
HC Wainwright sees Zevra’s Miplyffa launch and EU plans driving upside, initiating coverage with a $26 target and Buy rating on rare disease strength. read more
Read More
D-Wave Surges 1,326%: What’s Driving Quantum Computing’s Newest Star?
Cantor Fitzgerald analyst initiates coverage on D-Wave Quantum with Overweight rating and $20 price forecast. Company is leader in Quantum Annealing with proven business use cases. read more
Markets Calm As Trump’s July 9 Deadline Accelerates Diplomacy
So far, the market shows no signs of anxiety as the July 9 deadline for the Trump administration’s 90-day pause on tariffs draws near. read more
Congress Is Buying Into UnitedHealth’s 46% Crash — What Do They Know That Wall Street Doesn’t?
Congress members have been buying UnitedHealth shares worth thousands, after a massive earnings miss and retreat on 2025 guidance. read more
What’s Going On With SoundHound AI (SOUN) Stock?
Shares of SoundHound AI are trading higher Wednesday afternoon. In recent weeks, financial analysts have shown confidence in the voice AI company. read more
MARA Holdings Stock Is Moving Higher Wednesday: What’s Going On?
MARA Holdings, Inc. read more
Deep Dive Into Walmart Stock: Analyst Perspectives (23 Ratings)
Latest Ratings for WMT Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Raymond James Maintains Outperform Feb 2022 Deutsche Bank Maintains Buy View More Analyst Ratings for WMT View the Latest Analyst Ratings read more
Constellation Brands Navigates Soft Sales With Robust Beer Margins
Constellation Brands rose nearly 5% despite mixed Q1 results, as strong beer margins offset weak sales and lingering segment challenges. Latest Ratings for STZ Date Firm Action From To Feb 2022 Wells Fargo Maintains Overweight Jan 2022 Barclays Maintains Overweight Jan 2022 Credit Suisse Maintains Outperform View More Analyst Ratings for STZ View the Latest…
